135 related articles for article (PubMed ID: 2283668)
1. Strain and sex differences in the response of mice to drugs that induce protoporphyria: role of porphyrin biosynthesis and removal.
Holley A; King LJ; Gibbs AH; De Matteis F
J Biochem Toxicol; 1990; 5(3):175-82. PubMed ID: 2283668
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of the pathway of porphyrin synthesis in the liver of rats and mice by griseofulvin, 3,5-Diethoxycarbonyl-1,4-dihydrocollidine and related drugs: evidence for two basically different mechanisms.
De Matteis F; Gibbs AH
Biochem J; 1975 Jan; 146(1):285-7. PubMed ID: 1147902
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ferrochelatase and accumulation of porphyrins in mouse hepatocyte cultures exposed to porphyrinogenic chemicals.
Brady AM; Lock EA
Arch Toxicol; 1992; 66(3):175-81. PubMed ID: 1497480
[TBL] [Abstract][Full Text] [Related]
4. Formation of N-methyl protoporphyrin in chemically-induced protoporphyria. Studies with a novel porphyrogenic agent.
Frater Y; Brady A; Lock EA; De Matteis F
Arch Toxicol; 1993; 67(3):179-85. PubMed ID: 8494497
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanism of experimental porphyria and ferrochelatase inhibition produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine.
Tephly TR; Gibbs AH; Ingall G; De Matteis F
Int J Biochem; 1980; 12(5-6):993-8. PubMed ID: 7450161
[No Abstract] [Full Text] [Related]
6. Drug-induced conversion of liver haem into modified porphyrins. Evidence for two classes of products.
De Matteis F; Gibbs AH
Biochem J; 1980 Apr; 187(1):285-8. PubMed ID: 7406869
[TBL] [Abstract][Full Text] [Related]
7. Effects of porphyrin-inducing drugs on ferrochelatase activity in isolated mouse hepatocytes.
Cole SP; Massey TE; Marks GS; Racz WJ
Can J Physiol Pharmacol; 1981 Nov; 59(11):1155-8. PubMed ID: 7317839
[TBL] [Abstract][Full Text] [Related]
8. N-Methylprotoporphyrin IX: chemical synthesis and identification as the green pigment produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine treatment.
Ortiz de Montellano PR; Beilan HS; Kunze KL
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1490-4. PubMed ID: 6940170
[TBL] [Abstract][Full Text] [Related]
9. Hepatic protoporphyria is associated with a decrease in ligand binding for the mitochondrial benzodiazepine receptors in the liver.
Cantoni L; Rizzardini M; Skorupska M; Cagnotto A; Codegoni A; Pecora N; Frigo L; Ferrarese C; Mennini T
Biochem Pharmacol; 1992 Sep; 44(6):1159-64. PubMed ID: 1329761
[TBL] [Abstract][Full Text] [Related]
10. Experimental murine protoporphyria induced by griseofulvin (GF): the relationship between hepatic porphyrin levels and liver function test values in mice treated with GF.
Tanaka K; Ohgami T; Nonaka S
J Dermatol; 1993 Sep; 20(9):545-53. PubMed ID: 8227709
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of griseofulvin and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity in chick embryo liver.
Cole SP; Zelt DT; Marks GS
Mol Pharmacol; 1981 May; 19(3):477-80. PubMed ID: 7266472
[No Abstract] [Full Text] [Related]
12. Protoporphyrin hepatopathy. Effects of cholic acid ingestion in murine griseofulvin-induced protoporphyria.
Poh-Fitzpatrick MB; Sklar JA; Goldsman C; Lefkowitch JH
J Clin Invest; 1983 Oct; 72(4):1449-58. PubMed ID: 6630515
[TBL] [Abstract][Full Text] [Related]
13. Effect of Griseofulvin on 5-aminolevulinate synthase and on ferrochelatase in mouse liver neoplastic nodules.
Denk H; Kalt R; Abdelfattach-Gad M; Meyer UA
Cancer Res; 1981 Apr; 41(4):1535-8. PubMed ID: 7214331
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of protohaem ferro-lyase in experimental porphyria. Isolation and partial characterization of a modified porphyrin inhibitor.
De Matteis F; Gibbs AH; Tephly TR
Biochem J; 1980 Apr; 188(1):145-52. PubMed ID: 7406876
[TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanism of experimental porphyria produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Role of a porphyrin-like inhibitor of protohaem ferro-lyase.
Tephly TR; Gibbs AH; De Matteis F
Biochem J; 1979 Apr; 180(1):241-4. PubMed ID: 486100
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced porphyrin biosynthesis--XIX. Potentiation of the porphyrin-inducing effects of SKF 525-A in the chick embryo liver by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine, an antihibitor of ferrochelatase.
Cole SP; Vavasour EJ; Marks GS
Biochem Pharmacol; 1979 Dec; 28(24):0533-8. PubMed ID: 533555
[No Abstract] [Full Text] [Related]
17. Accumulation of protoporphyrin IX from delta-aminolevulinic acid in bovine skin fibroblasts with hereditary erythropoietic protoporphyria. A gene-dosage effect.
Sassa S; Schwartz S; Ruth G
J Exp Med; 1981 May; 153(5):1094-101. PubMed ID: 6788885
[TBL] [Abstract][Full Text] [Related]
18. Effect of decreased ferrochelatase activity on iron and porphyrin content in mitochondria of mice with porphyria induced by griseofulvin.
Tangerås A
Biochim Biophys Acta; 1986 Jun; 882(1):77-84. PubMed ID: 3707999
[TBL] [Abstract][Full Text] [Related]
19. Isolation of two N-monosubstituted protoporphyrins, bearing either the whole drug or a methyl group on the pyrrole nitrogen atom, from liver of mice given griseofulvin.
Holley AE; Frater Y; Gibbs AH; De Matteis F; Lamb JH; Farmer PB; Naylor S
Biochem J; 1991 Mar; 274 ( Pt 3)(Pt 3):843-8. PubMed ID: 2012610
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of griseofulvin and dihydropyridines on ferrochelatase activity and porphyrin accumulation in primary cultures of mouse and rat hepatocytes.
Brady AM; Hasmall RL; Elcombe BM
Toxicol In Vitro; 1993 Sep; 7(5):587-93. PubMed ID: 20732255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
